oxophenylarsine has been researched along with Insulin Resistance in 1 studies
oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carey, JO | 1 |
| Azevedo, JL | 1 |
| Morris, PG | 1 |
| Pories, WJ | 1 |
| Dohm, GL | 1 |
1 other study available for oxophenylarsine and Insulin Resistance
| Article | Year |
|---|---|
Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin-resistant human skeletal muscle.
Topics: Adult; Animals; Arsenicals; Biological Transport; Deoxyglucose; Ethers, Cyclic; Humans; Insulin Resi | 1995 |